|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/00 | |
| A61K 31/4184 | |||
| A61K 31/575 | |||
| A61K 39/395 | |||
| A61P 27/02 |
| (11) | Number of the document | 2187743 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08827362.8 |
| Date of filing the European patent application | 2008-08-18 | |
| (97) | Date of publication of the European application | 2010-05-26 |
| (45) | Date of publication and mention of the grant of the patent | 2014-07-30 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2008/073520 |
| Date | 2008-08-18 |
| (87) | Number | WO 2009/023877 |
| Date | 2009-02-19 |
| (30) | Number | Date | Country code |
| 965282 P | 2007-08-16 | US | |
| 965258 P | 2007-08-16 | US |
| (72) |
DOR, Philippe, Jm, US
MUDUMBA, Sreenivasu, US
NIVAGGIOLI, Thierry, US
WEBER, David, A., US
FAROOQ, Sidiq, US
TAKHAR, Sudeep, Kaur, US
|
| (73) |
Santen Pharmaceutical Co., Ltd,
9-19, Shimoshinjo 3-chome Higashiyodogawa-ku, Osaka 533-8651,
JP
|
| (54) | Rapamycin formulations for treatment of age related macular degeneration |
| Rapamycin formulations for treatment of age related macular degeneration |